Quarter Financials
Belite Bio, Inc (BLTE)
$28.02
+0.92 (+3.39%)
Retained Earning Schedule
| Year | 2022 Q2 | 2021 Q4 | null Q1 | null Q4 | null Q3 | null Q2 |
|---|---|---|---|---|---|---|
| Net Income | - | - | -2 | -2 | -2 | -2 |
| Dividend Paid | - | - | - | - | - | - |
| Retained Earnings | - | -27 | -7 | -4 | -7 | -7 |
PPE Schedule
| Year | 2022 Q2 | 2021 Q4 | null Q1 | null Q4 | null Q3 | null Q2 |
|---|---|---|---|---|---|---|
| Capital Expenditure | - | - | -0 | -0 | -0 | -0 |
| Net PPE | - | 0 | 0 | 0 | 0 | 0 |
Intangible and Goodwill Schedule
| Year | 2022 Q2 | 2021 Q4 | null Q1 | null Q4 | null Q3 | null Q2 |
|---|---|---|---|---|---|---|
| New Purchases | - | - | - | - | - | - |
| Intangible and Goodwill | - | - | - | - | - | - |